Skip to main content
MS Newbies: Recently Approved and Pipeline Drugs for the Treatment of Multiple Sclerosis

MS Newbies: Recently Approved and Pipeline Drugs for the Treatment of Multiple Sclerosis

1 hour
Credits / Contact Hours
$11
This course included in
AchieveCEPlans

Save 70% or more with a membership

License Renewal Money Back Guarantee

Course applies toward state CE requirements and hours needed for your FL RN license renewal. View Terms

30 Day Satisfaction Money Back Guarantee

This course is guaranteed to meet or exceed your expectations for convenience and quality. View Terms

Very well written, easy to digest, time efficient, and straight to the point. Thank you!

Da
Dawn O.
Verified review

I appreciate the convenience of the course being online and accessible through my phone and that it directly reports to support mandated education requirements.

Pr
Priya M.
Verified review

The course was well organized and helpful in meeting state licensure requirements. I found the content to be very informative and practical.

Cr
Cristina G.
Verified review

Course

Learn about the newest FDA-approved Multiple Sclerosis treatment agents, their efficacy, safety features, and critical drug/patient characteristics for appropriate treatment selection.

Nationally & state accredited

Pharmacy

Course Features

Instant certificates
All required courses
7-day live chat & phone support
Auto reporting toCPE Monitor
Unlimited course attempts

What you'll learn

Pharmacist Learning Objectives

At the conclusion of this continuing education activity, the participant will be able to:

  1. Discuss the mechanism of action of newly approved MS treatments

  2. Discuss the mechanism of action of pipeline multiple sclerosis treatments

  3. Discuss literature to date for approval of new agents and pending trials for pipeline MS treatments

Nurse / Pharmacy Technician Learning Objectives

At the conclusion of this continuing education activity, the participant will be able to:

  1. Review the mechanism of action of newly approved MS treatments

  2. Review how pipeline multiple sclerosis treatments work

  3. Discuss literature to date for approval of new agents and pending trials for pipeline MS treatments


Course description

The field of Multiple Sclerosis is ever-changing, with new targets and biomarkers being discovered each year. It can be challenging to stay up to date on newly approved agents given so many different components that play a role in treatment of Multiple Sclerosis. This activity will review the newest FDA-approved Multiple Sclerosis treatment agents including efficacy and safety features. This activity will also provide clinicians with drug/patient characteristics that are critical for appropriate treatment selection and recommendations.


Course content

  • Multiple Sclerosis (MS)

  • MS Disease Courses/Presentations

  • Impact of Multiple Sclerosis

  • Immunology of MS 

  • FDA Approvals for Multiple Sclerosis Disease Modifying Treatments

  • Ponesimod (Ponvory)

  • Sphingosine-1-phosphate Receptor

  • Sphingosine-1 Receptor Distribution and Biological Activity

  • Sphingosine-1 Phosphate Receptor Selectivity

  • Ponesimod Safety Considerations

  • Ponesimod Pre-testing/Assessments

  • Ponesimod Warnings

  • Ozanimod (Zeposia)

  • Sphingosine-1 Phosphate Receptor Selectivity

  • Monomethyl fumarate (Bafiertam)

  • Monomethyl fumarate

  • Monomethyl fumarate Mechanism of Action

  • A Tale of Two Fumarates

  • A Tale of Three Fumarates

  • GI Tolerability Study Findings

  • MMF vs DMF: Incidence of Moderate or Extreme MOGISS Scores

  • Monomethyl Fumarate: Clinical Considerations

  • Pipeline Drugs: Masitinib (AB1010) (Characteristics)

  • Pipeline Drugs: Masitinib (AB1010) (Blocks action of Mast Cells)

  • Why is masitinib considered so groundbreaking?

  • Study AB07002: Masitinib in primary progressive (PPMS) and nonactive secondary progressive (nSPMS) multiple sclerosis

  • Study AB07002 Results: Absolute Changes in EDSS from baseline

  • Study AB07002 Results: Mean of absolute change in EDSS 

  • Study AB07002 Results: Mean of absolute change in EDSS (39% Increased probability)

  • Study AB07002 Results: EDSS Worsening

  • Masitinib: Safety Findings

  • Masitinib: Clinical Considerations

  • Ofatumumab (Kesimpta)

  • Ofatumumab Mechanism of Action

  • Ofatumumab: Pre-treatment Considerations

  • B-cell Therapies in Multiple Sclerosis

  • Ofatumumab: Clinical Studies (ASCLEPIOS)

  • Ofatumumab: Clinical Studies (End Point)

  • Ofatumumab: Clinical Studies (B Disability Worsening Confirmed at 6 Mo

  • Ofatumumab: Clinical Studies (C Disability Improvement Confirmed at 6 Mo

  • Ofatumumab: Safety Considerations

  • All MS is NOT created equal


Course details

Release Date09/29/2024
Expiration Date09/29/2027
Review Date09/29/2027
ACPE UAN0657-0000-21-218-H01-P 0657-0000-21-218-H01-T
CE Broker ID20-890268
Activity TypeKnowledge-based
Activity FormatEnduring

Explore more continuing education topics


Instructor

avatar
Adrienne DeBerryPharmD, BCACP, CSP​

Dr. DeBerry received her Doctorate in Pharmacy from the University of Florida College of Pharmacy and completed two post-graduate residencies. She specializes in the areas of neurology, specialty pharmacy, and pain management. ​ ​As a clinic-based pharmacist, she provides education and training to healthcare providers and patients on various pharmacotherapeutic topics including multiple sclerosis. ​ ​She is also the founder of Real Talk Health Pro which teaches how to effectively navigate the world of specialty pharmacy for non-pharmacy health professionals.


Ideal CE course for these professions

This continuing education course is especially relevant for these healthcare professions, but other professionals may also benefit


Accreditations

Nursing financial disclosure
  • Arkansas State Board of Nursing

  • California Board of Nursing

  • District of Columbia Board of Nursing

  • District of Columbia Board of Nursing Assistive Personnel

  • Florida Board of Nursing

  • Florida Board of Nursing - Certified Nursing Assistants

  • Florida Board of Nursing Home Administrators

  • Georgia Board of Nursing

  • Kansas State Board of Nursing

  • Kentucky Board of Nursing

  • Michigan Board of Nursing

  • Mississippi Board of Nursing

  • New Mexico Board of Nursing

  • New Mexico Certified Nurse Midwives and Licensed Midwives

  • North Dakota Board of Nursing

  • South Carolina Board of Nursing

  • West Virginia Board of Registered Nurses

  • Wyoming Board of Nursing


Frequently asked questions

How many CE credits does this course provide?

This course, "MS Newbies: Recently Approved and Pipeline Drugs for the Treatment of Multiple Sclerosis", provides 1 contact hour of continuing education credit upon successful completion.

Is this course accredited?

Yes, this course is accredited by Nursing, Pharmacy. AchieveCE is an approved provider of continuing education for healthcare professionals.

Which professions is this course approved for?

This course is especially relevant for: Advanced Practice Nurse Prescribers, Pharmacist, Certified Nurse Midwife, Nursing Assistive Personnel, Certified Nurse Aides, Registered Nurse Practitioner, Advanced Practice Nurses, Forensic Nurse-CSA, Certified Registered Nurse Anesthetist, Psychiatric Nurse, Clinical Nurse Specialist, APRN - Certified Nurse Midwife, Licensed Practical Nurse, Licensed Psychiatric Technician Nurse, Nurse Practitioner, Registered Nurse, Licensed Nursing Assistant, Advanced Practice Registered Nurse, Public Health Nurse, Licensed Vocational Nurse, Nursing Home Administrator, Certified Nursing Assistant, Pharmacy Technician. Other healthcare professionals may also benefit from this continuing education content.

How do I report my CE credits after completing this course?

Your credits are automatically and instantly reported to CE Broker and CPE Monitor upon successful completion. No manual reporting is required on your part.

Will I receive a certificate of completion?

Yes, you will receive a certificate of completion immediately after finishing the course and passing the assessment. The certificate can be downloaded and printed directly from your account.

What is your refund policy?

We offer a 30-day money-back guarantee. If you are not satisfied with your purchase, you can request a full refund within 30 days of purchase.

How long do I have to complete this course?

You have unlimited time to complete the course at your own pace. Once purchased, the course is available in your account until its expiration date. You can pause and resume at any time.


Most helpful reviews

Star reviewsReal reviews, real results
Da
Dawn O.Nutritionist
Stars decorationVerified review
curly quote as a decorative item

I am always interested in continuing education in the areas of health, wellness, nutrition and mental health. Your course was well written, well organized and helpful in meeting state licensure requirements.

Pr
Priya M.Occupational Therapist
Stars decorationVerified review
curly quote as a decorative item

Very well written, easy to digest, time efficient, and straight to the point. Thank you!

Cr
Cristina GRegistered Nurse
Stars decorationVerified review
curly quote as a decorative item

I appreciate the convenience of the course being online and accessible through my phone and that it directly reports to CEBroker to support mandated education requirements.

Al
Allison B.Nurse Practitioner
Stars decorationVerified review
curly quote as a decorative item

I really loved this information. I was hospitalized last year for almost a month and I noticed multiple medical errors (not being hooked up to my IV multiple times, given wrong medication which caused my sodium to be very low, etc.) which lengthened my stay. I can now define those exact errors and better understand what happened to me. I hate that these medical errors are so common and I appreciate how well laid out your breakdown and categorization of them was.

Buy with confidence with money back guarantees

30 Day Satisfaction Money Back Guarantee

This course is guaranteed to meet or exceed your expectations for convenience and quality. View Terms

License Renewal Money Back Guarantee

Includes all state CE requirements and hours needed for your license renewal. View Terms


Requirements & disclosures

Financial Disclosures

This activity was developed by AchieveCE free of any commercial support. The following individuals have indicated that they have no financial relationships with an ineligible company that may impact upon this activity:

  • Adrienne DeBerry PharmD, BCACP, CSP​ - Content Expert and Faculty

  • Patricia Dunn, DNP, APRN, FNP-BC - Nurse Planner

  • Pete Kreckel, RPh - Pharmacist Planner

  • Gracielle Tubera - Content Reviewer

  • Luke Porter – Content Reviewer

  • Dianne Arroyo - Activity Publisher

Passing Grade

Participants must achieve a passing score on the activity post-test, which may be 70% or 80%, depending on the course. They must also complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CE Broker if your license information is entered correctly in your profile.

Hardware Requirements

Windows 8.1, Windows 10, Mac OS X 10.1+, iOS 10+, Android 4.3+

Software Requirements

Google Chrome, Microsoft Edge, Mozilla Firefox, Adobe Acrobat Reader

Network Requirements

Broadband Internet Connection: T1, Hi-speed DSL or Cable4G cellular connection


AchieveCEPlans

Save 70% or more with a membership

My cart